希荻微(688173.SH):實際控制人之一戴祖渝逝世
格隆匯5月6日丨希荻微(688173.SH)公佈,董事會沉痛公告,公司收到公司實際控制人之一戴祖渝女士家屬通知,戴祖渝女士於近日因病不幸逝世。公司董事、監事、高級管理人員及全體員工向戴祖渝女士致以崇高的敬意和衷心的感謝,對其逝世表示沉痛哀悼,並向其家人表示深切慰問。截至本公告披露之日,戴祖渝女士持有公司股份93,790,457股,佔公司總股本的22.86%。戴祖渝女士所持有的公司股份將按法律法規辦理繼承手續,公司將根據後續事項進展情況及時履行信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.